 The purpose of this study is to evaluate the activity and safety of telaprevir on Hepatitis C Virus HCV Genotype 4, alone or in combination with standard therapy, that is, pegylated-interferon-alfa-2a and ribavirin in treatment-naive never been treated before with antiretroviral therapy participants. 